Your browser doesn't support javascript.
loading
Differential response of pig masseter to botulinum neurotoxin serotypes a and b.
Liu, Zi-Jun; Rafferty, Katherine L; Ye, Wenmin; Herring, Susan W.
Afiliação
  • Liu ZJ; Department of Orthodontics, University of Washington, Box 357446, Seattle, WA, 98195-7446, USA.
  • Rafferty KL; Department of Orthodontics, University of Washington, Box 357446, Seattle, WA, 98195-7446, USA.
  • Ye W; Department of Orthodontics, University of Washington, Box 357446, Seattle, WA, 98195-7446, USA.
  • Herring SW; Department of Stomatology, No. 451 Hospital of PLA, Xi'an, P.R. China.
Muscle Nerve ; 52(1): 88-93, 2015 Jul.
Article em En | MEDLINE | ID: mdl-26039454
ABSTRACT

INTRODUCTION:

Pigs respond to direct administration of botulinum neurotoxins (BoNTs), although they are resistant to botulism. The human masseter is frequently targeted for BoNT therapy. We aimed to understand how BoNT affects chewing by injecting porcine masseters.

METHODS:

One masseter of minipigs was injected with BoNT serotype A or B at doses comparable to those used in humans. Masticatory function was evaluated electromyographically. Muscle force was measured during tetany. Four weeks after injection, strain gauges affixed to the mandible assessed bone strain during chewing. Masseter mass and fiber diameter were measured after euthanasia.

RESULTS:

BoNT-A had no measurable effect. In contrast, BoNT-B reduced electrical activity and muscle force, producing substantial asymmetry between injected and uninjected muscles.

CONCLUSIONS:

The pig masseter is highly resistant to direct injection of BoNT-A, but it is affected by BoNT-B.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxinas Botulínicas Tipo A / Músculo Masseter / Fármacos Neuromusculares Limite: Animals Idioma: En Revista: Muscle Nerve Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Toxinas Botulínicas Tipo A / Músculo Masseter / Fármacos Neuromusculares Limite: Animals Idioma: En Revista: Muscle Nerve Ano de publicação: 2015 Tipo de documento: Article País de afiliação: Estados Unidos